OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype‐Based Approach

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism: Clinical …, 2009 - Wiley Online Library
Background: Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …
被引用次数：105 相关文章
[HTML] nih.gov

[HTML][HTML] OPRM1 Asn40Asp predicts response to naltrexone treatment; a haplotype-based approach

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism, clinical …, 2009 - ncbi.nlm.nih.gov
Background Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …

OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism-Clinical …, 2009 - cdr.lib.unc.edu
Individualized pharmacotherapy requires identification of genetic variants predictive of
treatment response. In OPRM1, Asn40Asp has been reported to be predictive of response to …

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach

G Oroszi, RF Anton, S O'Malley… - Alcoholism, clinical …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …

[引用][C] OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach

G OROSZI - Alcohol. Clin. Exp. Res., 2009 - cir.nii.ac.jp
OPRM1 Asn40Asp predicts response to naltrexone treatment : a haplotype-based approach |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

[引用][C] OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

G OROSZI, RF ANTON, S O'MALLEY… - Alcoholism, clinical …, 2009 - pascal-francis.inist.fr
OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based
Approach CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism, Clinical …, 2008 - europepmc.org
Background Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …
[PDF] academia.edu

[PDF][PDF] OPRM1 Asn40Asp predicts response to naltrexone treatment; a haplotype-based approach

G Oroszi, MD Goldman - Alcohol Clin Exp Res, 2008 - academia.edu
Background—Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …

[引用][C] OPRM1Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism: Clinical …, 2009 - cir.nii.ac.jp

OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.

G Oroszi, RF Anton, S O'Malley, R Swift… - Alcoholism, Clinical …, 2008 - europepmc.org
Background Individualized pharmacotherapy requires identification of genetic variants
predictive of treatment response. In OPRM1, Asn40Asp has been reported to be predictive of …